All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

1,268

Reset

1,268 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • Fianlimab [Fixed ]Phase 22 trials

    Regeneron · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer

  • FL115Phase 22 trials

    Suzhou Forlong Biotechnology Co., Ltd · Advanced Solid Tumors, Non-muscle Invasive Bladder Cancer (NMIBC)

  • FMC-376Phase 22 trials

    Frontier Medicines Corporation · Advanced Solid Tumors With KRAS G12C Mutations, Solid Tumor, Adult, Unresectable Solid Tumor

  • FWD1802Phase 22 trials

    Forward Pharmaceuticals Co., Ltd. · Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Stage IV

  • GI-102Phase 22 trials

    GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Soft Tissue Sarcoma (STS)

  • GKL-006iNKT cellsPhase 22 trials

    Beijing Gene Key Life Technology Co., Ltd · Advanced Pancreatic Cancer, Ductal Adenocarcinoma of Pancreas, Hepatocellular Carcinoma (HCC)

  • GT201Phase 22 trials

    Grit Biotechnology · Advanced Solid Tumors, Advanced Solid Tumors Cancer

  • GW5282Phase 22 trials

    Dizal Pharmaceuticals · T-cell Lymphomas, Advanced Solid Tumors

  • HDM2017Phase 22 trials

    Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · CRC, Colorectal Cancer, Colorectal Cancer Metastatic

  • HH2853Phase 22 trials

    Haihe Biopharma Co., Ltd. · Relapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL), FL Lymphoma, Epithelioid Sarcoma

  • HRS-1167Phase 22 trials

    Jiangsu HengRui Medicine Co., Ltd. · Prostate Cancer

  • HRS-1358Phase 22 trials

    Shandong Suncadia Medicine Co., Ltd. · Advanced Unresectable or Metastatic Breast Cancer, Advanced Solid Tumors

  • HRS-5041Phase 22 trials

    Jiangsu HengRui Medicine Co., Ltd. · Prostate Cancer

  • HRS-6208Phase 22 trials

    Shandong Suncadia Medicine Co., Ltd. · Advanced Unresectable or Metastatic Breast Cancer of Adults, Prostate Cancer

  • HRS-9813Phase 22 trials

    Jiangsu HengRui Medicine Co., Ltd. · Advanced Unresectable or Metastatic Breast Cancer, Advanced Solid Tumors, IPF and PPF

  • IBB0979Phase 22 trials

    SUNHO(China)BioPharmaceutical CO., Ltd. · Small Cell Lung Cancer, Advanced Malignant Tumors

  • ICP-723Phase 22 trials

    Beijing InnoCare Pharma Tech Co., Ltd. · Advanced Solid Tumors Harboring NTRK Fusion, Primary Central Nervous System Tumors Harboring NTRK Fusion, Solid Tumors

  • IDP-121Phase 22 trials

    IDP Discovery Pharma S.L. · Small Cell Lung Cancer ( SCLC ), Multiple Myeloma (MM), Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

  • IMGN632Phase 22 trials

    AbbVie · Blastic Plasmacytoid Dendritic Cell Neoplasm, Myeloproliferative Neoplasm, Acute Myeloid Leukemia

  • ImzokitugBMS-986340Phase 22 trials

    Bristol Myers Squibb · Locally Advanced Non-Small Cell Lung Cancer (NSCLC), Metastatic Non-Small Cell Lung Cancer (NSCLC), Cervical Cancer

  • INO-5401Phase 22 trials

    Inovio Pharmaceuticals · Glioblastoma, Urothelial Carcinoma

  • T-MAXIMUM Pharmaceutical Inc · Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype, Brain Metastases From Solid Tumors

  • IPG7236Phase 22 trials

    Nanjing Immunophage Biotech Co., Ltd · Advanced Solid Tumor, Safety Issues, Tolerability

  • itacitinibINCB039110Phase 22 trials

    Incyte · B-Cell Malignancies, Lung Cancer

  • JAB-8263Phase 22 trials

    Jacobio Pharmaceuticals Co., Ltd. · Rheumatoid Arthritis (RA), NSCLC, SCLC

  • JMT108Phase 22 trials

    Shanghai JMT-Bio Inc. · Unresectable Locally Advanced or Metastatic Melanoma, Unresectable Locally Advanced or Metastatic Urinary Tract Tumors, Advanced Malignant Tumors

  • JS207Phase 22 trials

    Mabwell (Shanghai) Bioscience Co., Ltd. · Solid Tumor, Advanced Solid Tumor

  • KB707Phase 22 trials

    Krystal Biotech, Inc. · Cancer, Melanoma Stage III, Melanoma Stage IV

  • KCBT-1083BEBT-109Phase 22 trials

    BeBetter Med Inc · Non Small Cell Lung Cancer, Non-Small Cell Lung Cancer, EGFR Exon 20 Insertion Mutation

  • KN046Recombinant Humanized PD-L1, CTLA-4 Bispecific Single Domain Antibody Fc Fusion ProteinPhase 22 trials

    InxMed (Shanghai) Co., Ltd. · Pancreatic Cancer, Advanced Non-small Cell Lung Cancer

  • LM-168Phase 22 trials

    LaNova Medicines Limited · Advanced Solid Tumor, Advanced Solid Tumours

  • LM-24C5Phase 22 trials

    LaNova Medicines Limited · Advanced Solid Tumor, Advanced Solid Tumor Cancer

  • LM-364Phase 22 trials

    LaNova Medicines Limited · Advanced Solid Tumor Cancer, Malignant Tumors

  • LM103 TILsPhase 22 trials

    Suzhou BlueHorse Therapeutics Co., Ltd. · Advanced Melanoma, Non-Small Cell Lung Cancer

  • LorigerlimabMGD019Phase 22 trials

    MacroGenics · Platinum-resistant Ovarian Cancer, Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma

  • LS301-ITPhase 22 trials

    Integro Theranostics · Non Small Cell Lung Cancer (NSCLC), Breast Cancer, DCIS

  • LY188011Phase 22 trials

    Eli Lilly · Neoplasms, Child, Adolescent

  • M1774TuvusertibPhase 22 trials

    EMD Serono Research & Development Institute, Inc. · Non-Small Cell Lung Cancer, Ovarian Cancer

  • Monoclonal antibodyPhase 22 trials

    Immunocore Ltd · Cancer, HLA-A*02:01-positive, Refractory Cancer

  • MRG006APhase 22 trials

    Lepu Biopharma Co., Ltd. · Advanced Solid Tumors, Hepatocellular Carcinoma

  • MRT-2359Phase 22 trials

    Monte Rosa Therapeutics, Inc · Prostate Cancer, NSCLC, SCLC

  • MT-125Phase 22 trials

    Myosin Therapeutics Inc. · Glioblastoma (GBM), Glioblastoma

  • NBM-BMXPhase 22 trials

    Novelwise Pharmaceutical Corporation · Malignant Neoplasm of Brain, Malignant Neoplasm

  • NelistotugGSK6097608Phase 22 trials

    GSK · Lung Cancer, Non-Small Cell, Neoplasms, Head and Neck

  • NelmastobartPhase 22 trials

    STCube, Inc. · Metastatic Colorectal Cancer (CRC), Recurrent Colorectal Cancer, Non Small Cell Lung Cancer

  • NEO100Perillyl alcoholPhase 22 trials

    Neonc Technologies, Inc. · Glioblastoma Multiforme, Residual, Progressive or Recurrent Grade II or III Meningioma

  • NLM-001Phase 22 trials

    Nelum Corp · Untreated, Advanced Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma

  • ODM-212Phase 22 trials

    Orion Corporation, Orion Pharma · Solid Tumours, Mesothelioma, Pancreatic Cancer

  • Olaptesed pegolNOX-A12Phase 22 trials

    TME Pharma AG · Metastatic Pancreatic Cancer, Glioblastoma

  • ONC206JZP3507Phase 22 trials

    Jazz Pharmaceuticals · Meningioma, Advanced Pheochromocytoma and Paraganglioma, PCPG

NewerPage 12 of 26Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.